Search Results - "Schindler, A.E."

I290 Progesterone and progestins in pregnancy: Clinical relevance for treatment and prevention by Schindler, A.E.

Get full text

Progestogens and immunology by Szekeres-Bartho, J., Schindler, A.E.

“…Fifty percent of fetal antigens are of paternal origin. These are recognized by the maternal immune system, thereby resulting in lymphocyte activation and the…”
Get full text

Letter to the Editor by Schindler, A.E

Get full text

Multicenter phase II study of oral capecitabine (Xeloda“) in patients with metastatic breast cancer relapsing after treatment with a taxane-containing therapy by Reichardt, P., von Minckwitz, G., Thuss-Patience, P. C., Jonat, W., Kölbl, H., Jänicke, F., Kieback, D. G., Kuhn, W., Schindler, A. E, Mohrmann, S., Kaufmann, M., Lück, H. J.

“…Background: Capecitabine is a rationally designed oral, tumor-activated fluoropyrimidine carbamate with high activity in metastatic breast cancer. This…”
Get full text

Implementation of certified endometriosis centers: 5-year experience in German-speaking Europe by Ebert, A D, Ulrich, U, Keckstein, J, Müller, M, Schindler, A E, Sillem, M, Tinneberg, H-R, De Wilde, R L, Schweppe, K-W

“…The idea of quality improvement in the management of endometriosis has been brought to attention throughout Europe. This - first and foremost - includes the…”
Get more information

Prevention and treatment of pregnancy-induced hypertension (preeclampsia) with progestogens by Sammour, M.B., El-Kabarity, H., Fawzy, M.M., Schindler, A.E.

“…Available data indicate that progesterone is able to treat pregnancy-induced hypertension (preeclampsia). Dydrogesterone and 17α-hydroxyprogesterone caproate…”
Get full text

Reduced proliferation and cell adhesion in endometriosis by Scotti, S., Regidor, P.-A., Schindler, A.E., Winterhager, E.

“…Endometriosis is defined as endometriotic tissues growing outside the uterine cavity. The cell biological processes responsible for the pathogenesis of this…”
Get full text

The safety of synthetic paclitaxel by intralesional delivery with OncoGel™ into skin breast cancer metastases: method and results of a clinical pilot trial by Rohr, U. D., Oberhoff, C., Markmann, S., Gerber, B., Scheulen, M., Schindler, A.E.

Get full text

Topotecan chemotherapy in patients with breast cancer and brain metastases: results of a pilot study by Oberhoff, C, Kieback, D G, Würstlein, R, Deertz, H, Sehouli, J, van Soest, C, Hilfrich, J, Mesrogli, M, von Minckwitz, G, Staab, H J, Schindler, A E

“…Symptomatic brain metastases occur in approximately 10-15% of patients suffering from breast cancer and are linked to a clear deterioration of the patient's…”
Get more information

Studies on steroids in urine of the male newborn by Schindler, A E, Wuchter, J

“…Four different methods of isolation and purification were utilized to study steroids in urine of male newborns which was collected during the first 5 days of…”
Get more information

P14 Adjuvant tamoxifen treatment in breast cancer induces no activation of blood coagulation by Oberhoff, C., Winkler, U.H., Schindler, A.E.

Get full text

P15 Blood coagulation and fibrinolysis after oral or intravenous cyclophosphamide containing adjuvant CMF-chemotherapy by Oberhoff, C., Winkler, U.H., Schindler, A.E.

Get full text

Resistance to activated protein C due to the factor V Leiden mutation: a risk factor for chemotherapy-associated thrombosis by Oberhoff, C., Göge, S., Hoffmann, O., Winkler, U.H., Schindler, A.E.

Get full text

Computer based, temperature controlled bipolar electrocoagulation system by Kato, K, Bühler, K, Schindler, A.E

Get full text

A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 μg and 30 μg ethinylestradiol by Winkler, U.H., Schindler, A.E., Endrikat, J., Düsterberg, B.

“…The effects of two oral contraceptives, containing gestodene and either 20 μg or 30 μg ethinylestradiol, on hemostatic parameters was investigated in a…”
Get full text

Evaluation of different methods for the detection of minimal residual disease in blood and bone marrow of patients with primary breast cancer: importance for clinical use? by KASIMIR-BAUER, S, OBERHOFF, C, SLIWINSKA, K, NEUMANN, R, SCHINDLER, A. E, SEEBER, S

“…We studied cytokeratin-positive (CK+) cells in the bone marrow (BM) and tumor markers (TM) in the blood of 128 patients with primary breast cancer in order to…”
Get full text

Safety and efficacy profile of a high dose treatment of endometriosis with 20 mg dienogest per day by Moore, C., Schindler, A.E., Müller, A., Christensen, B.

Get full text

Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy : results of a randomized trial by KLOKE, O, KLAASSEN, U, DONSBACH, G.-M, BECHTEL, C, RUDOLPH, R, BERKE, A, BORQUEZ, D, HAWIG, I, HIRCHE, H, SCHINDLER, A. E, SEEBER, S, BECHER, R, OBERHOFF, C, HARTWICH, G, SZANTO, J, WOLF, E, HECKMANN, M, HUHN, R, STEPHAN, L, SCHNEPPER, U

“…The purpose of this randomized phase III trial was to study whether medroxyprogesterone acetate (MPA) maintenance treatment prolongs the time to progression in…”
Get full text

Comparison of leprorelin vs. lynestrenol in patients with endometriosis by Regidor, P.-A., Regidor, M., Lubben, G., Kienle, E., Fortig, P., Schindler, A.E.

Get full text

1245 Erythropoietin and chemotherapy: Effects on hemostasis and fibrinolysis by Oberhoff, C., Krummeich, B., Winkler, U.H., Schindler, A.E.

“…Data from hemodialysis patients who received erythropoietin (EPO) for anaemia report an increased incidence of thrombosis. We studied hemostasis in 13 patients…”
Get full text